Discover Products, Get Discovered.
Individuals find the right products. Businesses reach the right audience. One platform, free for both.
Individuals find the right products. Businesses reach the right audience. One platform, free for both.
Since 2025, Investing in Innovation (i3) has backed 4 African startups across 4 disclosed funding rounds totaling $800,000, most heavily in Health Tech.
Investing in Innovation (i3) is a health tech focused grant program that provides financial and technical support to early stage companies. It operates through the Investing in Innovation initiative, which offers structured grant funding for selected innovators in the healthcare and pharmaceutical value chain. A public contact for the program is listed via the Investing in Innovation website. In Africa, Investing in Innovation (i3) has provided grant funding to health tech companies in multiple markets. According to available investment records, the program has deployed 800,000 dollars across four grant rounds in April 2025, all at the grant stage. The program has backed RxAll in Nigeria, Meditect in Côte d'Ivoire, Dawa Mkononi in Tanzania, and Chefaa in Egypt, reflecting a focus on technology enabled solutions for medicine authentication, pharmacy management, credit for health facilities, and pharmacy delivery. These investments indicate a geographic focus that spans West, East, and North Africa within the health tech sector. Publicly available information also indicates that Investing in Innovation (i3) accepts applications from health tech innovators seeking grants and support, suggesting a structured intake process for new cohorts. The initiative positions itself around supporting scalable health technology solutions, particularly those improving access to quality medicines and strengthening pharmaceutical systems in African markets.
Data updated · Jul 22, 2026
Investing in Innovation (i3) has backed 4 African startups across 4 disclosed funding rounds tracked on Liners, totaling $800,000 since 2025.
Mostly Grant: 4 of its 4 tracked rounds are at that stage.
Companies Investing in Innovation (i3) has backed operate in Benin (1), Burkina Faso (1), Cameroon (1), and 15 more markets. Each figure counts the rounds behind companies serving that market, so a company operating in several markets counts in each of them.
Its tracked rounds lean toward Health Tech (4).
According to available data, Investing in Innovation (i3) has funded RxAll in Nigeria, Meditect in Côte d'Ivoire, Dawa Mkononi in Tanzania, and Chefaa in Egypt. All of these companies operate in health tech, offering solutions such as medicine authentication, pharmacy management, credit access for health facilities, and pharmacy delivery services.
Public information from the Investing in Innovation website shows that health tech innovators can apply for grants and support through an online application process. Applicants are invited to seek financial and non financial support to scale health technology solutions that improve access to quality medicines and strengthen pharmaceutical systems.
Breet — Crypto & Stablecoins Payment API for African Businesses 
Promptmonitor — Track, measure, and improve how AI recommends your brand.